Designing a Decision Tree for OOS Evaluation in Stability Testing
Out-of-Specification (OOS) results in stability testing can pose major regulatory and operational hurdles. A well-designed decision tree helps pharma professionals evaluate OOS outcomes systematically, ensuring compliance with USFDA, EMA, and other regulatory expectations. By clearly defining the path from initial detection to final disposition, organizations can streamline root cause analysis, reduce subjective judgments, and minimize…
Read More “Designing a Decision Tree for OOS Evaluation in Stability Testing” »